MovDisordV3, PascalFrancis, Curation, bibRecord, 001E53

Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy

Identifieur interne : 001E53 ( PascalFrancis/Curation ); précédent : 001E52; suivant : 001E54

Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy

Auteurs : Tatsuya Yamamoto [Japon] ; Ryuji Sakakibara [Japon] ; Tomoyuki Uchiyama [Japon] ; ZHI LIU [Japon] ; Takashi Ito [Japon] ; Yusuke Awa [Japon] ; Tomonori Yamanishi [Japon] ; Takamichi Hattori [Japon]

Source :

Movement disorders [ 0885-3185 ] ; 2009.

RBID : Pascal:09-0257357

Descripteurs français

Pascal (Inist)
- Atrophie multisystématisée, Pathologie du système nerveux, Questionnaire, Trouble fonctionnel, Qualité de vie.

English descriptors

KwdEn :
- Dysfunction, Multiple system atrophy, Nervous system diseases, Quality of life, Questionnaire.

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease characterized clinically by any combination of autonomic, cerebellar, and extrapyramidal symptoms. Autonomic symptoms are usually severe, and urinary symptoms are one of the cardinal features of MSA. Bowel dysfunction and sexual dysfunction are also common in MSA. Quality of life (QOL) in patients with MSA is severely impaired by the presence of pelvic organ dysfunction. Therefore, we aimed to examine the prevalence of pelvic organ dysfunction in patients with MSA. We recruited 256 patients with MSA seen at our neurology clinic. The mean age was 62 years. The control group comprised 158 individuals, and the mean age was 52 years. We administered a questionnaire on pelvic organ dysfunction to the MSA and control groups. The questionnaire had sections focusing on the bladder, bowel, and sexual function. Dysfunction, as described in the responses, was evaluated as normal, mild (>once a month), moderate (>once a week), or severe (>once a day). The Mann-Whitney's U-test was used for statistical analysis. When compared with the control group, the prevalence of pelvic organ dysfunction in the MSA group was significantly higher for urinary storage and voiding dysfunction, bowel dysfunction, and sexual dysfunction. QOL in the MSA group was therefore significantly impaired because of urinary dysfunction (70%, 76%), bowel dysfunction (40% of the men), and sexual dysfunction (26%, 45%). Pelvic organ dysfunction is common in MSA, and QOL is severely impaired in patients with MSA.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 24`
A06				`@2 7`
A08	`01`	`1`	`ENG`	`@1 Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy`
A11	`01`	`1`		`@1 YAMAMOTO (Tatsuya)`
A11	`02`	`1`		`@1 SAKAKIBARA (Ryuji)`
A11	`03`	`1`		`@1 UCHIYAMA (Tomoyuki)`
A11	`04`	`1`		`@1 ZHI LIU`
A11	`05`	`1`		`@1 ITO (Takashi)`
A11	`06`	`1`		`@1 AWA (Yusuke)`
A11	`07`	`1`		`@1 YAMANISHI (Tomonori)`
A11	`08`	`1`		`@1 HATTORI (Takamichi)`
A14	`01`			`@1 Department of Neurology, Chiba University @2 Chiba @3 JPN @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 8 aut.`
A14	`02`			`@1 Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University @2 Sakura @3 JPN @Z 2 aut.`
A14	`03`			`@1 Department of Urology, Chiba University @2 Chiba @3 JPN @Z 6 aut.`
A14	`04`			`@1 Department of Urology, Dokkyo Medical College @2 Tochigi @3 JPN @Z 7 aut.`
A20				`@1 972-978`
A21				`@1 2009`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000188271060030`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 15 ref.`
A47	`01`	`1`		`@0 09-0257357`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Multiple system atrophy (MSA) is a neurodegenerative disease characterized clinically by any combination of autonomic, cerebellar, and extrapyramidal symptoms. Autonomic symptoms are usually severe, and urinary symptoms are one of the cardinal features of MSA. Bowel dysfunction and sexual dysfunction are also common in MSA. Quality of life (QOL) in patients with MSA is severely impaired by the presence of pelvic organ dysfunction. Therefore, we aimed to examine the prevalence of pelvic organ dysfunction in patients with MSA. We recruited 256 patients with MSA seen at our neurology clinic. The mean age was 62 years. The control group comprised 158 individuals, and the mean age was 52 years. We administered a questionnaire on pelvic organ dysfunction to the MSA and control groups. The questionnaire had sections focusing on the bladder, bowel, and sexual function. Dysfunction, as described in the responses, was evaluated as normal, mild (>once a month), moderate (>once a week), or severe (>once a day). The Mann-Whitney's U-test was used for statistical analysis. When compared with the control group, the prevalence of pelvic organ dysfunction in the MSA group was significantly higher for urinary storage and voiding dysfunction, bowel dysfunction, and sexual dysfunction. QOL in the MSA group was therefore significantly impaired because of urinary dysfunction (70%, 76%), bowel dysfunction (40% of the men), and sexual dysfunction (26%, 45%). Pelvic organ dysfunction is common in MSA, and QOL is severely impaired in patients with MSA.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17F`
C03	`01`	`X`	`FRE`	`@0 Atrophie multisystématisée @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Multiple system atrophy @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Atrofia multisistematizada @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 02`
C03	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 02`
C03	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 02`
C03	`03`	`X`	`FRE`	`@0 Questionnaire @5 09`
C03	`03`	`X`	`ENG`	`@0 Questionnaire @5 09`
C03	`03`	`X`	`SPA`	`@0 Cuestionario @5 09`
C03	`04`	`X`	`FRE`	`@0 Trouble fonctionnel @5 10`
C03	`04`	`X`	`ENG`	`@0 Dysfunction @5 10`
C03	`04`	`X`	`SPA`	`@0 Trastorno funcional @5 10`
C03	`05`	`X`	`FRE`	`@0 Qualité de vie @5 11`
C03	`05`	`X`	`ENG`	`@0 Quality of life @5 11`
C03	`05`	`X`	`SPA`	`@0 Calidad vida @5 11`
N21				`@1 187`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000E66

Links to Exploration step

Pascal:09-0257357

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy</title>
<author><name sortKey="Yamamoto, Tatsuya" sort="Yamamoto, Tatsuya" uniqKey="Yamamoto T" first="Tatsuya" last="Yamamoto">Tatsuya Yamamoto</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University</s1>
<s2>Sakura</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Uchiyama, Tomoyuki" sort="Uchiyama, Tomoyuki" uniqKey="Uchiyama T" first="Tomoyuki" last="Uchiyama">Tomoyuki Uchiyama</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Zhi Liu" sort="Zhi Liu" uniqKey="Zhi Liu" last="Zhi Liu">ZHI LIU</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Ito, Takashi" sort="Ito, Takashi" uniqKey="Ito T" first="Takashi" last="Ito">Takashi Ito</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Awa, Yusuke" sort="Awa, Yusuke" uniqKey="Awa Y" first="Yusuke" last="Awa">Yusuke Awa</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Urology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Yamanishi, Tomonori" sort="Yamanishi, Tomonori" uniqKey="Yamanishi T" first="Tomonori" last="Yamanishi">Tomonori Yamanishi</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Urology, Dokkyo Medical College</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hattori, Takamichi" sort="Hattori, Takamichi" uniqKey="Hattori T" first="Takamichi" last="Hattori">Takamichi Hattori</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0257357</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0257357 INIST</idno>
<idno type="RBID">Pascal:09-0257357</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E66</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001E53</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy</title>
<author><name sortKey="Yamamoto, Tatsuya" sort="Yamamoto, Tatsuya" uniqKey="Yamamoto T" first="Tatsuya" last="Yamamoto">Tatsuya Yamamoto</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University</s1>
<s2>Sakura</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Uchiyama, Tomoyuki" sort="Uchiyama, Tomoyuki" uniqKey="Uchiyama T" first="Tomoyuki" last="Uchiyama">Tomoyuki Uchiyama</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Zhi Liu" sort="Zhi Liu" uniqKey="Zhi Liu" last="Zhi Liu">ZHI LIU</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Ito, Takashi" sort="Ito, Takashi" uniqKey="Ito T" first="Takashi" last="Ito">Takashi Ito</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Awa, Yusuke" sort="Awa, Yusuke" uniqKey="Awa Y" first="Yusuke" last="Awa">Yusuke Awa</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Urology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Yamanishi, Tomonori" sort="Yamanishi, Tomonori" uniqKey="Yamanishi T" first="Tomonori" last="Yamanishi">Tomonori Yamanishi</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Urology, Dokkyo Medical College</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hattori, Takamichi" sort="Hattori, Takamichi" uniqKey="Hattori T" first="Takamichi" last="Hattori">Takamichi Hattori</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dysfunction</term>
<term>Multiple system atrophy</term>
<term>Nervous system diseases</term>
<term>Quality of life</term>
<term>Questionnaire</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Atrophie multisystématisée</term>
<term>Pathologie du   système nerveux</term>
<term>Questionnaire</term>
<term>Trouble fonctionnel</term>
<term>Qualité de vie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple system atrophy (MSA) is a neurodegenerative disease characterized clinically by any combination of autonomic, cerebellar, and extrapyramidal symptoms. Autonomic symptoms are usually severe, and urinary symptoms are one of the cardinal features of MSA. Bowel dysfunction and sexual dysfunction are also common in MSA. Quality of life (QOL) in patients with MSA is severely impaired by the presence of pelvic organ dysfunction. Therefore, we aimed to examine the prevalence of pelvic organ dysfunction in patients with MSA. We recruited 256 patients with MSA seen at our neurology clinic. The mean age was 62 years. The control group comprised 158 individuals, and the mean age was 52 years. We administered a questionnaire on pelvic organ dysfunction to the MSA and control groups. The questionnaire had sections focusing on the bladder, bowel, and sexual function. Dysfunction, as described in the responses, was evaluated as normal, mild (>once a month), moderate (>once a week), or severe (>once a day). The Mann-Whitney's U-test was used for statistical analysis. When compared with the control group, the prevalence of pelvic organ dysfunction in the MSA group was significantly higher for urinary storage and voiding dysfunction, bowel dysfunction, and sexual dysfunction. QOL in the MSA group was therefore significantly impaired because of urinary dysfunction (70%, 76%), bowel dysfunction (40% of the men), and sexual dysfunction (26%, 45%). Pelvic organ dysfunction is common in MSA, and QOL is severely impaired in patients with MSA.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>24</s2>
</fA05>
<fA06><s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>YAMAMOTO (Tatsuya)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SAKAKIBARA (Ryuji)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>UCHIYAMA (Tomoyuki)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>ZHI LIU</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>ITO (Takashi)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>AWA (Yusuke)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>YAMANISHI (Tomonori)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>HATTORI (Takamichi)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University</s1>
<s2>Sakura</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Urology, Chiba University</s1>
<s2>Chiba</s2>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Urology, Dokkyo Medical College</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>972-978</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000188271060030</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>15 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0257357</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Multiple system atrophy (MSA) is a neurodegenerative disease characterized clinically by any combination of autonomic, cerebellar, and extrapyramidal symptoms. Autonomic symptoms are usually severe, and urinary symptoms are one of the cardinal features of MSA. Bowel dysfunction and sexual dysfunction are also common in MSA. Quality of life (QOL) in patients with MSA is severely impaired by the presence of pelvic organ dysfunction. Therefore, we aimed to examine the prevalence of pelvic organ dysfunction in patients with MSA. We recruited 256 patients with MSA seen at our neurology clinic. The mean age was 62 years. The control group comprised 158 individuals, and the mean age was 52 years. We administered a questionnaire on pelvic organ dysfunction to the MSA and control groups. The questionnaire had sections focusing on the bladder, bowel, and sexual function. Dysfunction, as described in the responses, was evaluated as normal, mild (>once a month), moderate (>once a week), or severe (>once a day). The Mann-Whitney's U-test was used for statistical analysis. When compared with the control group, the prevalence of pelvic organ dysfunction in the MSA group was significantly higher for urinary storage and voiding dysfunction, bowel dysfunction, and sexual dysfunction. QOL in the MSA group was therefore significantly impaired because of urinary dysfunction (70%, 76%), bowel dysfunction (40% of the men), and sexual dysfunction (26%, 45%). Pelvic organ dysfunction is common in MSA, and QOL is severely impaired in patients with MSA.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17F</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Atrophie multisystématisée</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Multiple system atrophy</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Atrofia multisistematizada</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Questionnaire</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Questionnaire</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Cuestionario</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Trouble fonctionnel</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dysfunction</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Trastorno funcional</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Qualité de vie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Quality of life</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Calidad vida</s0>
<s5>11</s5>
</fC03>
<fN21><s1>187</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E53 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001E53 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:09-0257357
   |texte=   Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy

Questionnaire-Based Assessment of Pelvic Organ Dysfunction in Multiple System Atrophy

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri